The United States CTEPH Proceedings 2021

Earn up to 10 CME Credits!

The United States CTEPH Proceedings 2021 will provide a multidisciplinary framework for the evaluation and management of patients with chronic thromboembolic pulmonary hypertension (CTEPH). Covered topics will include:

  • The epidemiology of chronic thromboembolic disease in the US
  • Contemporary approaches to diagnosing CTEPH
  • The latest in surgical advancements
  • The role of pulmonary hypertension (PH) targeted medical therapy and balloon pulmonary angioplasty (BPA) in the management of inoperable CTEPH

The conference format will comprise didactic presentations, debates, and panel discussions involving national and international experts in the field. There will be scheduled opportunities throughout the symposium for interactive audience participation. Attendees will also be encouraged to submit and present scientific abstracts and unique clinical cases related to CTEPH and other large-vessel pulmonary vascular diseases.

Target Audience:

This program has been designed to provide internists, pulmonologists, cardiologists, cardiovascular surgeons, interventional cardiologists and radiologists, anesthesiologists, thoracic radiologists, nurses, and allied healthcare professionals with state-of-the-art information to evaluate and manage patients with CTEPH.

Learning Objectives:

  1. Discuss an updated understanding of the epidemiology and pathophysiology of CTEPH
  2. Describe the latest diagnostic and evaluative approaches to patients with suspected chronic thromboembolic disease and apply that information to a patient case
  3. Discuss advances in pulmonary thromboendarterectomy for patients with chronic thromboembolic disease and CTEPH and apply that information to a patient case
  4. Explain the role of balloon pulmonary angioplasty in the management of inoperable CTEPH and apply that information to a patient case
  5. Define the role of medical therapy in selected patient groups with CTEPH and apply that information to a patient case

Conference Chair:

  • William R. Auger, MD

Organizing Committee:

  • Sonja Bartolome, MD (University of Texas, Southwestern)
  • Todd Bull, MD (University of Colorado)
  • Richard N. Channick, MD (University of California, Los Angeles)
  • Michael Cuttica, MD (Northwestern University)
  • Gustavo Heresi, MD (Cleveland Clinic)
  • Michael M. Madani, MD (University of California, San Diego)
  • Vallerie McLaughlin, MD (University of Michigan)
  • Ivan Robbins, MD (Vanderbilt University)
  • Anjali Vaidya, MD (Temple University)
  • Alison Witkin, MD (MGH, Harvard University)


In-Person Cost:

NATF will work closely with the College of Physicians to create a safe environment in compliance with all Philadelphia public safety guidelines, which may include:

  • Socially distant seating
  • Face masks/coverings for all staff and guests
  • Single-person catering (rather than open buffets)
  • Enhanced cleaning and sanitation protocols

NATF will require proof of COVID-19 vaccination at check-in for all attendees at our live, in-person programs. A digital or physical copy of a COVID-19 vaccine card is considered acceptable proof of vaccination.

If you are unable to comply with this policy, please register for the virtual, live-stream offering of this course

  • MD/DO: $500
  • Nursing and Allied Healthcare Professionals: $250
  • Fellows and Residents: $175
  • Commercial: $650
  • Students: $0 *no CME offered for this registration
  • Your tuition includes
    • 10 CME/CPE/CE credits
    • Continental breakfast
    • Morning and afternoon coffee breaks
    • Lunch
    • Cocktail/Networking Reception
    • Complimentary internet in the meeting room
    • All attendees will receive a printed syllabus

Virtual Cost:

  • MD/DO: $400
  • Nursing and Allied Healthcare Professionals: $150
  • Fellows and Residents: $75
  • Commercial: $550
  • Students: $0 * no CME/CPE/CE offered for this registration
  • Your tuition includes
    • Program will be streamed live with the opportunity to submit questions to presenters in real-time
    • 10 CME/CPE/CE credits
    • PDF version of the syllabus

As a provider of continuing medical education and continuing pharmacy education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME/CPE/CE activity. For this CME/CPE/CE activity, any COI has been resolved thru content review ScientiaCME. ScientiaCME adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME/CPE/CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests) or lack thereof. All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Accreditation Information and Obtaining Credit:

Physicians: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of ScientiaCME and NATF. ScientiaCME is accredited by the ACCME to provide continuing medical education for physicians. ScientiaCME designates this live course educational activity for a maximum of 10 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nurse Practitioners (NPs): The American Academy of Nurse Practitioners accepts AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME. ScientiaCME will provide NPs who successfully complete each activity with a certificate of participation indicating that the activity was designated for AMA PRA Category 1 Credit(s)™.

Physician Assistants: The American Academy of Physician Assistants accepts AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME.

Nurses: may claim credit for activities approved for AMA PRA Category 1 Credit(s)™ in most states for up to 50% of the nursing requirement for recertification. Nursing board continuing education requirements for re-licensure vary state-by-state.

Medical Practice Executives: The American College of Medical Practice Executives accepts AMA PRA Category 1 Credit(s)TM from organizations accredited by ACCME.


ScientiaCME is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This program is approved for 10 hours (1.0 CEUs) of continuing education. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the post-test. 

Participants have 1 calendar month after the activity to provide learner information and complete the post-activity assessment and evaluation. ACPE #0574-9999-21-009-L01-P. This activity is an Assessment (A)-type activity.

Successful completion of the post-activity assessment and completion of the ACTIVITY evaluation is required to obtain a certificate of completion.


To complete the post-assessment, please visit

This online evaluation and CE credit will not be accessible after 10/10/2021. Successful completion of the post-test with a score of 70% and completion of the program evaluation is required to obtain a CME certificate.


This program is supported by an educational grant from Abbott Laboratories, Actelion Pharmaceuticals US, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson, Bayer US, and Boston Scientific.

Additional details for this past event are no longer available.